Molecular Modeling in Drug Design
1
Heidelberg Institute for Theoretical Studies (HITS), Schloss-Wolfsbrunnenweg 35, 69118 Heidelberg, Germany
2
Zentrum für Molekulare Biologie der Universität Heidelberg (ZMBH), DKFZ-ZMBH Alliance, Im Neuenheimer Feld 282, and Interdisciplinary Center for Scientific Computing (IWR), Im Neuenheimer Feld 205, 69120 Heidelberg, Germany
3
Pharmaceutical Sciences Laboratory and Structural Bioinformatics Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Biocity, Tykistökatu 6 A, FI 20520 Turku, Finland
*
Authors to whom correspondence should be addressed.
Molecules 2019, 24(2), 321; https://doi.org/10.3390/molecules24020321
Received: 14 January 2019 / Accepted: 15 January 2019 / Published: 17 January 2019
(This article belongs to the Special Issue Molecular Modeling in Drug Design)
Note: In lieu of an abstract, this is an excerpt from the first page.
This Special Issue contains thirteen articles that provide a vivid snapshot of the state-of-the-art of molecular modeling in drug design, illustrating recent advances and critically discussing important challenges [...] View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Wade, R.C.; Salo-Ahen, O.M.H. Molecular Modeling in Drug Design. Molecules 2019, 24, 321. https://doi.org/10.3390/molecules24020321
AMA Style
Wade RC, Salo-Ahen OMH. Molecular Modeling in Drug Design. Molecules. 2019; 24(2):321. https://doi.org/10.3390/molecules24020321
Chicago/Turabian StyleWade, Rebecca C.; Salo-Ahen, Outi M.H. 2019. "Molecular Modeling in Drug Design" Molecules 24, no. 2: 321. https://doi.org/10.3390/molecules24020321
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit
